Advances in Drug Discovery & Development 2025

The drug discovery landscape is rapidly evolving with the integration of new technologies and methodologies. Returning for 2025, this event will focus on small molecule and biologic drug development, high-throughput screening and novel target identification strategies.

• Explore the latest advances in small molecule and biologic drug development strategies
• Understand how high-throughput screening and automation are accelerating the discovery process
• Discover how AI and machine learning are transforming hit-to-lead and predictive modeling pipelines
• Learn best practices for translating drug candidates into preclinical development and IND-enabling studies
• Discuss regulatory expectations and strategic considerations for early-stage drug programs

• Pharmaceutical and Biotech Scientists focused on early drug development, screening and lead optimization
• Molecular and Cell Biologists working in target identification and validation
• R&D Leaders and Project Managers driving innovation across therapeutic pipelines

• "An excellent snapshot of where the future of drug discovery is heading—great insights and actionable ideas!" - Senior Research Scientist

• "I appreciated the focus on both biologics and small molecules—very comprehensive and well-curated sessions." - Principal Investigator